Helena Jaczek

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA) PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. NET ZERO: Advocate for sustainable health systems in Canada, including reaching net-zero emissions by 2050; advocate for the establishment of a national climate and health secretariat within the federal government to develop a pan-Canadian approach to addressing the impacts of climate change and health; and advocate for a targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure. MEDICAL ASSISTANCE IN DYING: Advancing the medical profession’s perspectives on medical assistance in dying. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. INDIGENOUS HEALTH AND RECONCILIATION WITH INDIGENOUS PEOPLES: Implementation of the Calls to Action of the Truth and Reconciliation Commission, including addressing the ongoing structural inequities that marginalize Indigenous Peoples, advancing the inclusion of Indigenous Peoples in societal systems and sectors, including health systems, and committing to collaborative and respectful relationships with Indigenous patients and communities. The CMA is also advocating to increase trust between Ind

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs Improve safeguards for Canadian health data Improve labour mobility so physicians can work across the country Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Cauc

The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs Improve safeguards for Canadian health data Improve labour mobility so physicians can work across the country Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. THE ACQUISITION AND THE DOMESTIC SUPPLY OF PERSONAL PROTECTIVE EQUIPMENT FOR HEALTH CARE PROVIDERS: Ensuring the federal government take additional measures ensure adequate supply, proper distribution, and appropriate usage of personal protective equipment throughout health systems. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to

YOUNG TRAINEES AND STUDENTS: Advocate for continued support of and investment in the next generation of highly skilled researchers through the federal awards system for doctoral students, post-doctoral trainees and fellows. RESEARCH HOSPITALS: Advocate for direct support and stability for Canada's academic health science centres and research hospitals that will further enable them to fulfill their strategically critical contribution to Canada's health and economic security. INDUSTRY: Advocate for policies that enhance the health and biosciences sector’s capacity to do business in Canada and to invest in Canadian health research and commercialization. INDIRECT COSTS OF RESEARCH: Advocate for an increase to the minimum threshold for reimbursement of indirect research costs for all institutions via the Research Support Fund. INDIGENOUS RESEARCH: Advocate for greater investments in Indigenous health research through the three granting councils and the Canada Research Coordinating Committee. HEALTH RESEARCH: Focus on increasing public investments across the research spectrum of operating grants, people and infrastructure and encourages investments from private and private-not-for-profit sectors. GOVERNMENT FUNDING: Advocate for increased health research funding through the three granting councils (Canadian Institutes of Health Research, Social Sciences and Humanities Research Council, and Natural Sciences and Engineering Research Council of Canada) and the Canada Research Coordinating Committee. FEDERAL BUDGET CONSULTATION: Advocate for continued support of Canadian health research and health innovation through investments and commitments made in the federal budget, such as the Strategic Science Fund, the Canada Graduate Scholarship Program, etc. DIVERSE TALENT BASE: Advocate for better support for a diversified talent base in Canada, with a focus on Indigenous researchers, Black and people of colour researchers, early-career researchers, and other underrepresented and equity-deserving groups. DIGITAL HEALTH SYSTEM: Advocate for investment in the digitalization of our health system so that high-quality data and digital technologies support healthcare decisions, empower patients as partners, and drive research and innovation.

Raising awareness about York University's strengths in research, teaching, and scholarship and differentiation among post-secondary institutions in Canada Seeking to raise awareness about York University’s strengths in the health sector, as well as the York University School of Medicine. Seeking funding from the federal government for an increased federal investment in Canada Graduate Scholarships Seeking funding from federal government for investment in regional development projects Inquire on the status of grants and to propose a wide variety of academic research projects to Federal Research Granting Councils (NSERC, SSHRC, CIHR)- Advocating for continued and increased granting council funding. Immigration policy related to students Advocating for institutional infrastructure investments from various federal programs. Advocating for increases in funding for research and innovation, as well as funding to the Indirect Costs Program of SSHRC, NSERC, CIHR Advocating for increased investment in student assistance with the Canada Student Loan Program.

Canada's Drug Agency policies as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry. Federal policies that relate to possible models of pharmacare Federal Buy Canadian Procurement Policy as it relates to government drug procurement practices and the implications for the biopharmaceutical industry Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations National Strategy for Drugs for Rare Diseases World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the biopharmaceutical industry World Health Organization (WHO) issues concerning the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Income Tax Act as it relates to biopharmaceutical products Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade agreements as they relate to the biopharmaceutical industry Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry

World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the protection of and access to intellectual property World Health Organization (WHO) issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernmental Working Group (IGWG) The government's Science and Technology strategy as it relates to the biopharmaceutical industry Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations Smart Regulations as it relates to the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Proposed pharmacare legislation related to any future national pharmacare program Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products New Substances Notification Regulations as it relates to the biopharmaceutical industry Income Tax Act as it relates to biopharmaceutical products Health Canada’s Interim Orders relating to COVID-19: The Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19; The Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19; The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19; The Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade treaty agreement as they relate to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH) Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies Canada-United States Regulatory Cooperation Council (RCC) initiatives related to the regulation of biopharmaceutical products Canada's Food and Consumer Safety Action Plan as it relates to the regulation and protection of biopharmaceutical products Canada's Access to Medicines Regime with respect to ensuring that the program allows for the deli

Raise awareness of the burden of musculoskeletal (MSK) conditions and the need for more strategic approach to management of MSK health for federal populations including Canadian Forces, Veterans, RCMP and First Nations and Inuit. Inclusion of chiropractors as recognized qualified practitioners to issue the Disability Tax Credit Certificate(T2201). Improve chiropractic coverage for federal public service employees. Improve access to chiropractic care for Indigenous peoples, particularly by adding coverage for chiropractic services under the Non-Insured Health Benefits Program. Implement the Canadian Pain Task Force's Action Plan for Pain in Canada and enhance the current approach to pain management by improving the integration of non-pharmacological treatments, such as chiropractic care. Expand the Canada Student Loan Forgiveness Program to include front-line allied health care professionals, such as Doctors of Chiropractic. Ensure that the Canadian Armed Forces paid education programs in health care include chiropractic. Ensure that chiropractors are included in the government's plan to introduce a one-time income tax deduction for health care professionals starting their careers in rural communities. -Allow refugees and refugee claimants to access chiropractic care under the Interim Federal Health Program (IFHP).

Raise awareness of the burden of musculoskeletal (MSK) conditions and the need for more strategic approach to management of MSK health for federal populations including Canadian Forces, Veterans, RCMP and First Nations and Inuit. Inclusion of chiropractors as recognized qualified practitioners to issue the Disability Tax Credit Certificate(T2201). Improve chiropractic coverage for federal public service employees. Improve access to chiropractic care for Indigenous peoples, particularly by adding coverage for chiropractic services under the Non-Insured Health Benefits Program. Implement the Canadian Pain Task Force's Action Plan for Pain in Canada and enhance the current approach to pain management by improving the integration of non-pharmacological treatments, such as chiropractic care. Expand the Canada Student Loan Forgiveness Program to include front-line allied health care professionals, such as Doctors of Chiropractic Ensure that the Canadian Armed Forces paid education programs in health care include chiropractic. Ensure that chiropractors are included in the government's plan to introduce a one-time income tax deduction for health care professionals starting their careers in rural communities. -Allow refugees and refugee claimants to access chiropractic care under the Interim Federal Health Program (IFHP).

That the Government of Canada amend the proposed increase to the capital gains tax inclusion rate to except healthcare clinics Raise awareness of the burden of musculoskeletal (MSK) conditions and the need for more strategic approach to management of MSK health for federal populations including Canadian Forces, Veterans, RCMP and First Nations, Metis, and Inuit. Inclusion of chiropractors as recognized qualified practitioners to issue the Disability Tax Credit Certificate(T2201). Improve chiropractic coverage for federal public service employees. Improve access to chiropractic care for Indigenous peoples, particularly by adding coverage for chiropractic services under the Non-Insured Health Benefits Program. Implement the Canadian Pain Task Force's Action Plan for Pain in Canada and enhance the current approach to pain management by improving the integration of non-pharmacological treatments, such as chiropractic care. Expand the Canada Student Loan Forgiveness Program to include front-line allied health care professionals, such as Doctors of Chiropractic. Ensure that the Canadian Armed Forces paid education programs in health care include chiropractic. Ensure that chiropractors are included in the government's plan to introduce a one-time income tax deduction for health care professionals starting their careers in rural communities. Allow refugees and refugee claimants to access chiropractic care under the Interim Federal Health Program (IFHP).

Connected Care for Canadians Act (BILL S-5) : Urging federal policy makers to adopt this legislation quickly and to ensure that it is supported by a robust set of regulations. Provide CFPC's perspective on Federal Budget 2025's initiative to “Improving Access to Health Care in the Arctic and the North”. Funds should be directed to supporting family practices, as part of the Federal government's Health Infrastructure Fund announced in Budget 2025. Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. Support family doctors with teams, as that is a key enabler to providing high quality primary care Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms. Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system.

Connected Care for Canadians Act (BILL S-5) : Urging federal policy makers to adopt this legislation quickly and to ensure that it is supported by a robust set of regulations. Provide CFPC's perspective on Federal Budget 2025's initiative to “Improving Access to Health Care in the Arctic and the North”. Funds should be directed to supporting family practices, as part of the Federal government's Health Infrastructure Fund announced in Budget 2025. Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats. Support family doctors with teams, as that is a key enabler to providing high quality primary care Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms.

Support family doctors with teams, as that is a key enabler to providing high quality primary care. Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms.

The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors. Public Health Agency of Canada, regarding the federal response to the hepatitis C virus. Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada. Innovation, Science and Economic Development (ISED)'s Biomanufacturing and Life Sciences Strategy, pertaining to growth and development of the life sciences industry in Canada. Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages. Communications with Heath Canada regarding modernization of the medical devices regulatory framework. Communications with Health Canada regarding the evolution of the regulatory framework to address advanced therapeutic products. Communications with Health Canada regarding the application of its nitrosamine guidelines. Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials. Communications with Health Canada regarding guidelines for pediatric action plans. Communications regarding the value assessment of new medicines by the Canadian Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors. Communications regarding the design and implementation of the federal Drugs for Rare Diseases strategy. Communications regarding national pharmacare legislation, regulations, policies or programs. Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime. Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices. Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.

Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape. Innovation, Science and Economic Development (ISED)'s Health Emergency Readiness program, insofar as it pertains to growth and development of the life sciences industry in Canada. Communication regarding free trade agreements as they relate to the biopharmaceutical industry. The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors. Public Health Agency of Canada, regarding the federal response to the hepatitis C virus. Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada. Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages. Communications with Heath Canada regarding modernization of the medical devices regulatory framework. Communications with Health Canada regarding the evolution of the regulatory framework to address advanced therapeutic products. Communications with Health Canada regarding the application of its nitrosamine guidelines. Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials. Communications with Health Canada regarding guidelines for pediatric action plans. Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors. Communications regarding the design and implementation of the federal Drugs for Rare Diseases strategy. Communications regarding national pharmacare legislation, regulations, policies or programs. Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime. Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices. Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.

Discussing the development and implementation of measures to eliminate forced labour in supply chains. Discussing aerospace industry skilled labour requirements, including government immigration and employment support programs. Strategic Response Fund (SRF) – this program administered by ISED Canada co-invests with Canadian aerospace companies in funding their Research & Development (R&D) projects. AIAC advocates to ensure that the program’s mandate, funding level, and investment terms and conditions align to the R&D financing needs of Canadian aerospace companies and that they are equivalent to what other countries provide their aerospace companies. Strategic Response Fund (SRF) - proposal to support the development of an ecosystem in Canada by providing an environment for the pursuit of collaborative projects. Industrial and Technological Benefits (ITB) Policy – AIAC advocates to the government for a policy framework and eligibility rules that ensure high quality industrial benefits are placed into Canada by the primes. Discussing regional development in the province of British Columbia. Discussing the aerospace industry perspective on international trade negotiations and agreements to ensure their effectiveness. Discussing Canadian export controls and trade measures, including the Canada-United States-Mexico Agreement, to provide the industry’s perspective and ensure their effectiveness. Discussing how Transport Canada can improve its resources and governance structure for civil aviation, including improvements to certification processes and alignment with bilateral partners. Communications regarding the implementation of the Defence Industrial Strategy, including related policies, programs, regulations and legislation which support production capacity of the aerospace industry in Canada, increase supports for export opportunities and development of international markets. Ensuring the Defence Industrial Strategy implementation, including related policies, programs, regulations and legislation supports the growth of the aerospace industry in Canada. Advocate on current or future environmental, legislation, policy or regulations of potential impact. The Aeronautics Act and Canadian Aviation Regulations (CARs) - AIAC advocates for internationally harmonized implementation of regulations to get the highest practical level of safety and to keep Canadian industry economically competitive. Taxation Policy – AIAC advocates for a taxation policy regime that strengthens Canada as a place for new aerospace investment and for growing existing aerospace businesses. e.g. lowering of corporate taxation rates, allowing for greater and accelerated write-up of the purchase of new capital and equipment. Scientific Research & Experimental Development (SRED) Tax Credit – this program administered by Revenue Canada provides a tax credit to companies in proportion to their investments in Research & Development. AIAC advocates for eligibility rules and terms and conditions that meet the needs of Canadian aerospace companies regardless of their public or private ownership. Safety Management System (SMS) - The development of an internationally-recognized SMS Standard consistent with Annex 19. Obtain support from relevant government departments in dealing with the European Union Emissions Trading Scheme to ensure fairness to Canadian companies. Export Financing – Export Development Canada provides financing assistance to foreign buyers of Canadian products and systems. AIAC advocates for adequate financing support of aerospace exports and that the program's terms and conditions are aligned to market circumstances as well as keeping Canada's industry competitive internationally. Enhancement and growth of the Canadian Aviation Maintenance Council to cover all aviation human resource issues with particular focus on aerospace manufacturing, human resource issues; to include possible funding and activities Employment Insurance Policy – administered by Emp

Infrastructure funding for municipalities of City of Markham and Town of Whitchurch Stoufville to facilitate land development for housing

Discuss details and provide information to elected officials, minister, staff and officials regarding the request for AI funding to support Brain Research Invite Ministers and MPs to attend research announcements on behalf of the government. Seeking funds from Health Canada through the Canadian Brain Research Fund to continue to support Brain Research across Canada.

Brain Canada Foundation is seeking a top-up to its current funding to support the development and application of AI to accelerate research, advance our understanding of the brain, and identify solutions for brain diseases and disorders. Brain Canada Foundation is seeking additional funding to increase the Canada Brain Research Fund, which is currently funded by the Government of Canada, through Health Canada, and which current funding expires March 31, 2028. Brain Canada Foundation wishes to engage the Government on policy development issues related to medical research support, mental health, Indigenous health, and sex and gender diversity in the medical and research fields.